Senores Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals Limited has submitted a statement of deviation(s) or variation(s) to the stock exchange under Regulation 32 of SEBI's Listing Obligations and Disclosure Requirements (LODR). This regulation requires companies to report any deviations from the originally stated purpose of utilizing funds raised through public issues, rights issues, or preferential allotments. The specific details regarding the amount involved, the nature of the deviation, and the revised use of proceeds have not been disclosed in this headline. Investors would need to refer to the full filing on the exchange portal for complete information.
Investors should review the detailed filing to understand how the company's use of proceeds has changed from its original plan, as such deviations can affect future growth plans and shareholder confidence. The immediate stock price impact is likely neutral unless the deviation is material and unexpected.